BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barruet E, Morales BM, Cain CJ, Ton AN, Wentworth KL, Chan TV, Moody TA, Haks MC, Ottenhoff TH, Hellman J, Nakamura MC, Hsiao EC. NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification. JCI Insight 2018;3:122958. [PMID: 30429363 DOI: 10.1172/jci.insight.122958] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Gregson CL, Bergen DJM, Leo P, Sessions RB, Wheeler L, Hartley A, Youlten S, Croucher PI, McInerney-Leo AM, Fraser W, Tang JC, Anderson L, Marshall M, Sergot L, Paternoster L, Davey Smith G, Brown MA, Hammond C, Kemp JP, Tobias JH, Duncan EL; AOGC Consortium. A Rare Mutation in SMAD9 Associated With High Bone Mass Identifies the SMAD-Dependent BMP Signaling Pathway as a Potential Anabolic Target for Osteoporosis. J Bone Miner Res 2020;35:92-105. [PMID: 31525280 DOI: 10.1002/jbmr.3875] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
2 Huang Y, Wang X, Zhou D, Zhou W, Dai F, Lin H. Macrophages in heterotopic ossification: from mechanisms to therapy. NPJ Regen Med 2021;6:70. [PMID: 34702860 DOI: 10.1038/s41536-021-00178-4] [Reference Citation Analysis]
3 Li J, Sun Z, Luo G, Wang S, Cui H, Yao Z, Xiong H, He Y, Qian Y, Fan C. Quercetin Attenuates Trauma-Induced Heterotopic Ossification by Tuning Immune Cell Infiltration and Related Inflammatory Insult. Front Immunol 2021;12:649285. [PMID: 34093537 DOI: 10.3389/fimmu.2021.649285] [Reference Citation Analysis]
4 Kaliya-Perumal AK, Carney TJ, Ingham PW. Fibrodysplasia ossificans progressiva: current concepts from bench to bedside. Dis Model Mech 2020;13:dmm046441. [PMID: 32988985 DOI: 10.1242/dmm.046441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Zhang D, Huang J, Sun X, Chen H, Huang S, Yang J, Du X, Tan Q, Luo F, Zhang R, Zhou S, Jiang W, Ni Z, Wang Z, Jin M, Xu M, Li F, Chen L, Liu M, Su N, Luo X, Yin L, Zhu Y, Feng JQ, Chen D, Qi H, Chen L, Xie Y. Targeting local lymphatics to ameliorate heterotopic ossification via FGFR3-BMPR1a pathway. Nat Commun 2021;12:4391. [PMID: 34282140 DOI: 10.1038/s41467-021-24643-2] [Reference Citation Analysis]
6 de Ruiter RD, Smilde BJ, Pals G, Bravenboer N, Knaus P, Schoenmaker T, Botman E, Sánchez-Duffhues G, Pacifici M, Pignolo RJ, Shore EM, van Egmond M, Van Oosterwyck H, Kaplan FS, Hsiao EC, Yu PB, Bocciardi R, De Cunto CL, Longo Ribeiro Delai P, de Vries TJ, Hilderbrandt S, Jaspers RT, Keen R, Koolwijk P, Morhart R, Netelenbos JC, Rustemeyer T, Scott C, Stockklausner C, Ten Dijke P, Triffit J, Ventura F, Ravazzolo R, Micha D, Eekhoff EMW. Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop. Front Endocrinol (Lausanne) 2021;12:732728. [PMID: 34858325 DOI: 10.3389/fendo.2021.732728] [Reference Citation Analysis]
7 Rauner M, Seefried L, Shore E. Genetics and future therapy prospects of fibrodysplasia ossificans progressiva. Medizinische Genetik 2020;31:391-6. [DOI: 10.1007/s11825-019-00279-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nascimento DR, Balaniuc SLB, Palhares DB, Underwood A, Palhares MG, Alves F, Vieira FO, Souza-Fagundes EM, Giuliani LR, Xavier PCN, Puerto HLD, Santos RAS, Milsted A, Brum JM, Silva IS, Martins AS. Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment. Intractable Rare Dis Res 2021;10:179-89. [PMID: 34466340 DOI: 10.5582/irdr.2021.01012] [Reference Citation Analysis]
9 Lin Y, Chen M, Zhang S, Feng Z, Wang J. Influence on proliferation and apoptosis of intestinal epithelial cells and expression of ACVR1 by Helicobacter pylori. Eur J Inflamm 2021;19:205873922098710. [DOI: 10.1177/2058739220987108] [Reference Citation Analysis]
10 Kou S, Kile S, Kambampati SS, Brady EC, Wallace H, De Sousa CM, Cheung K, Dickey L, Wentworth KL, Hsiao E. Social and Clinical Impact of COVID-19 on Patients with Fibrodysplasia Ossificans Progressiva. Res Sq 2021:rs. [PMID: 34545360 DOI: 10.21203/rs.3.rs-885603/v1] [Reference Citation Analysis]
11 Kou S, Kile S, Kambampati SS, Brady EC, Wallace H, De Sousa CM, Cheung K, Dickey L, Wentworth KL, Hsiao EC. Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva. Orphanet J Rare Dis 2022;17:107. [PMID: 35246171 DOI: 10.1186/s13023-022-02246-4] [Reference Citation Analysis]
12 Lyu H, Elkins CM, Pierce JL, Serezani CH, Perrien DS. MyD88 Is Not Required for Muscle Injury-Induced Endochondral Heterotopic Ossification in a Mouse Model of Fibrodysplasia Ossificans Progressiva. Biomedicines 2021;9:630. [PMID: 34206078 DOI: 10.3390/biomedicines9060630] [Reference Citation Analysis]
13 Kondkar AA, Sultan T, Azad TA, Osman EA, Almobarak FA, Al-Obeidan SA. Association analysis of polymorphisms rs12997 in ACVR1 and rs1043784 in BMP6 genes involved in bone morphogenic protein signaling pathway in primary angle-closure and pseudoexfoliation glaucoma patients of Saudi origin. BMC Med Genet 2020;21:145. [PMID: 32641001 DOI: 10.1186/s12881-020-01076-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep 2019;39:BSR20191805. [PMID: 31548362 DOI: 10.1042/BSR20191805] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Matsuo K, Chavez RD, Barruet E, Hsiao EC. Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification. Curr Osteoporos Rep 2019;17:387-94. [PMID: 31721068 DOI: 10.1007/s11914-019-00541-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
16 Dai G, Li Y, Liu J, Zhang C, Chen M, Lu P, Rui Y. Higher BMP Expression in Tendon Stem/Progenitor Cells Contributes to the Increased Heterotopic Ossification in Achilles Tendon With Aging. Front Cell Dev Biol 2020;8:570605. [PMID: 33102476 DOI: 10.3389/fcell.2020.570605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Smilde B, Botman E, de Ruiter R, Smit JM, Teunissen B, Lubbers W, Schwarte LA, Schober P, Eekhoff EMW. Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives. ORR 2022;Volume 14:113-20. [DOI: 10.2147/orr.s337491] [Reference Citation Analysis]
18 Matsuo K, Lepinski A, Chavez RD, Barruet E, Pereira A, Moody TA, Ton AN, Sharma A, Hellman J, Tomoda K, Nakamura MC, Hsiao EC. ACVR1R206H extends inflammatory responses in human induced pluripotent stem cell-derived macrophages. Bone 2021;153:116129. [PMID: 34311122 DOI: 10.1016/j.bone.2021.116129] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Wei Z, Guo S, Wang H, Zhao Y, Yan J, Zhang C, Zhong B. Comparative proteomic analysis identifies differentially expressed proteins and reveals potential mechanisms of traumatic heterotopic ossification progression. Journal of Orthopaedic Translation 2022;34:42-59. [DOI: 10.1016/j.jot.2022.04.003] [Reference Citation Analysis]
20 Kondkar AA, Azad TA, Sultan T, Osman EA, Almobarak FA, Al-Obeidan SA. Association of rs12997 variant in the ACVR1 gene: a member of bone morphogenic protein signaling pathway with primary open-angle glaucoma in a Saudi cohort. J Investig Med 2021;69:402-7. [PMID: 33443061 DOI: 10.1136/jim-2020-001596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Grgurević L, Novak R, Trkulja V, Hamzić LF, Hrkač S, Grazio S, Santini M. Elevated plasma RANTES in fibrodysplasia ossificans progressiva - A novel therapeutic target? Med Hypotheses 2019;131:109313. [PMID: 31443758 DOI: 10.1016/j.mehy.2019.109313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Khan F, Yu X, Hsiao EC. Cardiopulmonary and Neurologic Dysfunctions in Fibrodysplasia Ossificans Progressiva. Biomedicines 2021;9:155. [PMID: 33562570 DOI: 10.3390/biomedicines9020155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Pignolo RJ, Wang H, Kaplan FS. Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome. Front Endocrinol (Lausanne) 2019;10:908. [PMID: 31998237 DOI: 10.3389/fendo.2019.00908] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
24 Sun Z, Li J, Luo G, Liu W, He Y, Wang F, Qian Y, Fan C. Pharmacological activation of SIRT1 by metformin prevented trauma-induced heterotopic ossification through inhibiting macrophage mediated inflammation. Eur J Pharmacol 2021;909:174386. [PMID: 34332919 DOI: 10.1016/j.ejphar.2021.174386] [Reference Citation Analysis]
25 Ravazzolo R, Bocciardi R. Genomic Context and Mechanisms of the ACVR1 Mutation in Fibrodysplasia Ossificans Progressiva. Biomedicines 2021;9:154. [PMID: 33562470 DOI: 10.3390/biomedicines9020154] [Reference Citation Analysis]
26 Eekhoff EMW, de Ruiter RD, Smilde BJ, Schoenmaker T, Vries TJ, Netelenbos C, Hsiao EC, Scott C, Haga N, Grunwald Z, De Cunto CL, Di Rocco M, Delai P, Diecidue R, Madhuri V, Cho TJ, Morhart R, Friedman C, Zasloff M, Pals G, Shim JH, Gao G, Kaplan F, Pignolo RJ, Micha D. Gene therapy for Fibrodysplasia Ossificans Progressiva (FOP): feasibility and obstacles. Hum Gene Ther 2022. [PMID: 35502479 DOI: 10.1089/hum.2022.023] [Reference Citation Analysis]
27 Wang Z, Liang X, Xiong A, Ding L, Li W, Yang L, Wu X, Shi H, Zhou Y, Wang Z. Helichrysetin and TNF‑α synergistically promote apoptosis by inhibiting overactivation of the NF‑κB and EGFR signaling pathways in HeLa and T98G cells. Int J Mol Med 2021;47:49. [PMID: 33576459 DOI: 10.3892/ijmm.2021.4882] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Haviv R, Moshe V, De Benedetti F, Prencipe G, Rabinowicz N, Uziel Y. Is fibrodysplasia ossificans progressiva an interleukin-1 driven auto-inflammatory syndrome? Pediatr Rheumatol Online J 2019;17:84. [PMID: 31864380 DOI: 10.1186/s12969-019-0386-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]